홈
마켓
차트 & 아이디어
Algo
뉴스
Store
브로커
다운로드
경제 달력
트레이딩 시그널
웹터미널
검색
/
타입: @user, $symbol
검색
로그인
계정을 생성하십시오
한국어
English
Русский
中文
Español
Português
日本語
Deutsch
Français
Italiano
Türkçe
LUCD
#3107
Lucid Diagnostics Inc. Common Stock
1.4
4
-2.04%
부문:
베이스:
수익 통화:
일일 변동 비율
년간 변동
일일 변동
-2.04%
월간 변동
+20.00%
6달 변화
+13.39%
년간 변동율
-4.00%
이전 종가
1.4
7
Open
1.4
4
Bid
Ask
Low
1.4
4
High
1.4
4
양
32
마켓
주식
헬스케어
LUCD
Open full chart
Financials
Overview
성명
Statistics
Dividends
Quarterly
Annual
Value
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
37.43 M
43.39 M
48.24 M
90.75 M
—
Valuation ratios
Enterprise value
147.36 M
37.84 M
66.79 M
106.36 M
564.87 M
Price to earnings ratio
—
0.9
-1.1
-0.78
-4.34
Price to sales ratio
—
133.37
24.18
9.62
62.36
Price to cash flow ratio
—
1.69
1.77
0.94
6.17
Price to book ratio
—
2.18
-3.56
-0.84
-2.05
Enterprise value to EBITDA ratio
-5.38
-0.25
—
—
—
Profitability ratios
Return on assets %
0.48
1.73
1.93
1.48
1.51
Return on equity %
0.51
2.44
22.79
8.45
8.11
Return on invested capital %
4 002.77
2 672.42
877.18
662.87
630.4
Gross margin %
17
100
100
100
400
Operating margin %
5 483.8
14.9 K
2 020.08
1 070.98
4 564.52
EBITDA margin %
-5 483
-40.91 K
—
—
—
Net margin %
5 615.6
14.9 K
2 194.42
1 058.81
5 602.53
Liquidity ratios
Quick ratio
—
—
0.74
1.05
4.81
Current ratio
22.01
2.89
0.75
1.07
4.87
Inventory turnover
—
—
—
—
—
Asset turnover
0.01
0.01
0.08
0.15
0.13
Solvency ratios
Debt to assets ratio
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
Long term debt to total assets ratio
—
—
0.51
0.61
2.68
Long term debt to total equity ratio
—
—
6.06
3.45
13.63
Per share metrics
Operating cash flow per share
—
0.82
0.79
0.87
0.58
EBIT per share
—
-4.32
—
—
—
EBITDA per share
—
-4.26
—
—
—
Total debt per share
—
—
—
—
—
Cash per share
—
0.62
0.45
0.44
1.56
Net current asset value per share
—
0.67
0.53
0.5
1.7
Tangible book value per share
—
0.54
-0.42
-0.99
-2.45
Working capital per share
—
0.44
-0.18
0.03
0.16
Book value per share
—
0.64
-0.39
-0.97
-2.42
뉴스
Teleflex (TFX) Q4 Earnings and Revenues Miss Estimates
Veracyte (VCYT) Q4 Earnings and Revenues Surpass Estimates
Lucid Diagnostics Q4 실적 예상치를 넘어, 수익 에상치보다 저조
Lucid Diagnostics earnings beat, revenue fell short of estimates
Orthofix (OFIX) Q4 Earnings and Revenues Lag Estimates
Inogen (INGN) Soars 6.6%: Is Further Upside Left in the Stock?
PAVmed raises $45 million, restructures capital to eliminate convertible debt
Lucid Diagnostics: Green Flags, But Dilution And Friction Keep Me Neutral (LUCD)
What's Going On With PAVmed Shares Thursday? - PAVmed (NASDAQ:PAVM)
루시드 다이애그노스틱스, VA 계약 체결 후 주가 급등
Lucid Diagnostics stock surges after securing VA contract for cancer test
Why Is PAVmed Stock Skyrocketing Wednesday? - Lucid Diagnostics (NASDAQ:LUCD), PAVmed (NASDAQ:PAVM)